Patients having a high PAR1 protein level showed a significant shorter overall survival time which is in accordance with data from Zhang and colleagues who showed that PAR1 protein in malignant glioma is correlated with both the malignancy grade and a shortened survival of patients (17). The gene discussed is F2R; the disease is malignant glioma.